Researchers at the University of Cologne and the Center for Genomic Regulation (CRG) in Barcelona have discovered that cancer ...

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for ...

A new report is calling on the government to consider the economic impacts of changing gene technology regulations on New Zealand's key primary sector exports, before it progresses with legislative ...